Feedback
The current prices are delayed. Login to see live prices.
Panacea Biotec Ltd.
(PANACEABIO)
301234567892012345678940123456789.0012345678900123456789
-17.45 (-5.11%)
Updated 15:59 21/02 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
₹320.55
Today's high
₹349.2
52 week low
₹107
52 week high
₹490.55
Open
₹339
Prev Close
₹341.45
Volume (shares)
136,984
Total Trading Value
4.68 Cr
Technicals
SMA
Value
Signal
12-SMA
357.58
Bearish
20-SMA
353.95
Bearish
50-SMA
399.14
Bearish
100-SMA
382.56
Bearish
200-SMA
279.69
Bullish
Discussions
• Feb 17 5:15 AM
Panacea Biotec - Quarterly Results
Earnings Update...read more
• Feb 16 3:46 AM
Changes in Directorate Announced by Panacea Biotec
• Panacea Biotec has announced the appointment and re-appointment of...read more
• Feb 16 3:31 AM
Panacea Biotec Announces Changes in Directorate
• Panacea Biotec approved the re-appointment of Mr. Sandeep Jain and...read more
• Feb 15 8:01 PM
Panacea Biotec Releases Unaudited Financial Results for Q3 FY2025
• Panacea Biotec's Board approved the unaudited financial results fo...read more
• Feb 15 12:58 AM
Panacea Biotec Announces Key Management Changes
• Mr. Sandeep Jain and Mr. Ankesh Jain are re-appointed as Joint Man...read more
• Feb 13 12:30 AM
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of Panacea Biotec Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of Panacea Biotec Ltd. is Rs 341.45 as of 21 February 2025.
What is the Market Capitalization of Panacea Biotec Ltd. ?
The current market cap of Panacea Biotec Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of Panacea Biotec Ltd.?
Panacea Biotec Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.
What is the 52-week high/low of Panacea Biotec Ltd.?
The 52-week high of Panacea Biotec Ltd. is Rs 490.55 and the 52-week low is Rs 107
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2025